Sigma Healthcare Ltd

Sigma Healthcare Ltd's next confirmed earnings release is scheduled for March 4, 2027.

As of June 30, 2026, Sigma Healthcare Ltd has 11.50B shares outstanding.

As of June 30, 2026, Sigma Healthcare Ltd maintains a current ratio of 1.67, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 40.50, indicating elevated leverage, while an interest coverage ratio of 21.37 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Sigma Healthcare Ltd posted a return on equity (ROE) of 14.67, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 9.02 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 8.25, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 10.81, useful for judging operating efficiency across full business cycles. Inventory turnover of 7.84 indicates how many times Sigma Healthcare Ltd sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Sigma Healthcare Ltd recorded 179.55M in income tax expense. That works out to an effective tax rate of 29.49, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 608.82M, leaving 429.58M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Over the twelve months ended June 30, 2026, Sigma Healthcare Ltd generated 6.56B in revenue and converted that into 429.58M in net income, yielding earnings per share of 0.04. EBITDA reached 600.93M, while operating income came in at 549.42M.

As of June 30, 2026, Sigma Healthcare Ltd holds 79.43M in cash and equivalents against 1.22B in total debt, resulting in a net debt position of 401.75M. Total book value stands at 3.03B, with working capital of 833.69M providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Sigma Healthcare Ltd posted a gross margin of 18.06, reflecting its pricing power and cost economics. The operating margin of 8.37 and net profit margin of 6.55 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Sigma Healthcare Ltd paid dividends of 0.02 per share. The dividend payout ratio of 53.50 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth.

Sigma Healthcare Ltd's most recent stock split took place on December 13, 2023.